% Expired Patents = 40.0

Forward Citations = 3

Loading Chart...

3 inventors (with patents filed for the assignee):

Paul DaSilva-Jardine (5 out of 5 patents)

Hans De Haard (5 out of 20 patents)

James A Landro (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 11248042 - Polynucleotides encoding anti-ApoC3 antibodies (2022-02-15),

2. 11248041 - Anti-ApoC3 antibodies (2022-02-15),

3. 11242381 - Anti-ApoC3 antibodies and methods of use thereof (2022-02-08),

4. 11091539 - Anti-ApoC3 antibodies and methods of use thereof (2021-08-17),

5. 10538583 - Anti-APOC3 antibodies and compositions thereof (2020-01-21),

Company Overview

Staten Biotechnology B.v. is a biotechnology company that focuses on the development of novel therapeutics for the treatment of cancer and other diseases. The company is dedicated to advancing innovative research and leveraging cutting-edge technology to bring new and improved treatment options to patients. With a team of experienced scientists and researchers, Staten Biotechnology is committed to making a positive impact on healthcare worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#16 in Nijmegen

#1,131 in Netherlands

Nijmegen, Netherlands

Staten Biotechnology B.v.

Forward Citations = 3

3 inventors:

Paul DaSilva-Jardine (5 out of 5 patents)

Hans De Haard (5 out of 20 patents)

James A Landro (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Staten Biotechnology B.v.. Retrieved from https://idiyas.com/company/staten-biotechnology-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]